I. Research Layout and Directions

The School of Pharmaceutical Sciences aligns its scientific research with new trends in pharmaceutical development. We focus on the five pillars: small molecules, biomacromolecules, genes, cell therapy, and medical devices. This breaks through traditional subject classification to emphasize distinctive characteristics and interdisciplinary development. The school carries out drug discovery and pharmaceutical research in three general directions: key biological issues of pharmacy, key technology research of pharmacy, and disease research and targeted therapy, covering such important branches of contemporary pharmaceutical research as quantitative and systematic pharmacology, pharmacogenomics, drug development science and medical engineering, new techniques for target identification, disease models, pharmaceutical informatics, drug delivery and preparations, etc.

II. Current Research Team and Achievements

At present, the School of Pharmaceutical Sciences has a world-class scientific research team composed of 33 scientists. Almost all PIs have the background of education and scientific research at top overseas research institutes. Many researchers are selected into national talent programs, and some possess valuable experience in drug research and development. In specific pharmaceutical frontier fields such as pain/tactile ion channels, translocators, chemical synthesis of natural drugs, pharmaceutical chemistry, vaccine adjuvants, physical pharmaceutics, stem cells, immune recognition, chemical biology, high-throughput and high-content screening, etc., they have established rich academic research accumulation, achieved a series of innovative research results, and promoted the research on the transformation of multiple original drugs.

III. Future Plans for Talent Attraction and Research Expansion

The School of Pharmaceutical Sciences takes active measures to attract top talents at home and abroad. We plans to make rational layout in the frontier research fields of pharmacy, and strengthen the leading position of current research directions. We aims to cover more key branches of pharmacy, and further improve the overall scientific research level. In the next ten years, the size of PIs will increase to 60, and in each main research direction, the school will form an outstanding research echelon led by internationally renowned scholars and driven by excellent young and middle-aged scholars.